Improving the R&D advantages,as the company’s sustainable competitiveness.

Bellingbio continuously challenges herself and aspires to new development progress in the bile acid field. Over twenty years of efforts, Bellingbio has also established a library of more than 100 bile acid component structures and a reference standard library of more than 50 bile acid components, successfully integrated a comprehensive industrial chain from bile acid products R&D and API production to formulation R&D. 

With an area of nearly 10000m2, Bellingbio R&D is equipped with world-class precision instruments and equipment for API chemical synthesis, biosynthesis, biological enzymes preparation and formulation R&D, and has R&D capabilities from raw materials to complex formulations.